financetom
Business
financetom
/
Business
/
Vishay Intertechnology Insider Sold Shares Worth $597,096, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vishay Intertechnology Insider Sold Shares Worth $597,096, According to a Recent SEC Filing
Mar 6, 2024 6:29 AM

09:07 AM EST, 03/06/2024 (MT Newswires) -- Marc Zandman, Director, ExecChairman & Chief Bus Dev, on March 04, 2024, sold 26,154 shares in Vishay Intertechnology ( VSH ) for $597,096. Following the Form 4 filing with the SEC, Zandman has control over a total of 73,678 shares of the company, with 73,678 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/103730/000010373024000059/xslF345X03/form4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Moderna Shares Fall After Cutting Annual R&D Spending by $1.1 Billion From 2027
Update: Moderna Shares Fall After Cutting Annual R&D Spending by $1.1 Billion From 2027
Sep 13, 2024
11:09 AM EDT, 09/12/2024 (MT Newswires) -- (Updates with the latest stock movement in the headline and the first paragraph.) Moderna ( MRNA ) shares fell more than 18% in recent Thursday trading after the company said it is reducing its annual R&D expense by about $1.1 billion starting in 2027 in light of recent commercial challenges. The company now...
--Street Color: US FDA Authorizes Over-the-Counter Hearing Aid Software for Apple's AirPods Pro
--Street Color: US FDA Authorizes Over-the-Counter Hearing Aid Software for Apple's AirPods Pro
Sep 13, 2024
11:09 AM EDT, 09/12/2024 (MT Newswires) -- Price: 222.76, Change: +0.10, Percent Change: +0.04 ...
Oncternal Therapeutics Ends Clinical Studies, Explores Strategic Options; Shares Fall
Oncternal Therapeutics Ends Clinical Studies, Explores Strategic Options; Shares Fall
Sep 13, 2024
11:13 AM EDT, 09/12/2024 (MT Newswires) -- Oncternal Therapeutics' ( ONCT ) shares sank 58% in recent Thursday trading after the company said it has decided to discontinue its clinical studies and explore strategic alternatives. The company also said it will discontinue all product development activities, lay off some staff, and implement other cost-cutting measures while exploring alternatives, which may...
Hurricane disruption to oil and gas output grows, some energy ports reopen
Hurricane disruption to oil and gas output grows, some energy ports reopen
Sep 13, 2024
HOUSTON, Sept 12 (Reuters) - U.S. energy producers on Thursday were assessing the extent of damage from Hurricane Francine to their U.S. Gulf of Mexico infrastructure while export ports in southern Texas began to reopen. Hurricane Francine hit the Louisiana coast with up to 100 mile per hour winds (161 kph), knocking out power to 375,000 customers and bringing heavy...
Copyright 2023-2026 - www.financetom.com All Rights Reserved